Aristotelis Kourtis1, Panagiotis G Adamopoulos2, Apostolos Papalois3, Dimitrios C Iliopoulos4, George C Babis5, Andreas Scorilas2. 1. Athens Medical Centre, Athens, Greece. 2. Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Athens, Greece. 3. Experimental - Research Center ELPEN, PIkermi, Attica, Athens, Greece. 4. National and Kapodistrian University of Athens, Medical School, Athens, Greece. 5. Second Orthopaedic Department, National and Kapodistrian University of Athens Medical School, Konstantopouleio General Hospital, Athens, Greece.
Abstract
BACKGROUND: Given that apoptosis of chondrocytes is one of the most important factors related to the pathogenesis of osteoarthritis (OA), the recent research interest adds progress not only to the knowledge of the molecular signals that mediate apoptosis but also to find new therapeutic targets. This study attempts to investigate the differential expression of BCL2 family genes in the articular cartilage of an experimental animal model of OA. METHODS: In total, 26 New Zealand white rabbits underwent an anterior cruciate ligament transaction, 26 more were subjected to a placebo surgery and 18 specimens constituted the control non-operated group. Thirteen weeks later, samples of cartilage from the osteoarthritic and non-osteoarthritic knees were collected and subjected to analysis of the BCL2, BAX and BCL2L12 gene expression at the mRNA level. RESULTS: Installed osteoarthritic alterations of varied intensity and of grade 1 up to grade 5, were confirmed according to the OARSI system. Contrary to the physiologically healthy samples, in the osteoarthritic samples the mRNA expression levels of BAX and BCL2L12 genes were found significantly upregulated by signals which can activate apoptosis. However, the difference between BCL2 mRNA expression levels in healthy and osteoarthritic samples was not supported statistically. CONCLUSIONS: Since apoptosis is the main feature of the cartilage degeneration in OA, the effective inhibition of apoptosis of chondrocytes can provide novel and interesting therapeutic strategies for the treatment of OA. Therefore, BAX and BCL2L12 are highlighted as potential therapeutic targets in OA.
BACKGROUND: Given that apoptosis of chondrocytes is one of the most important factors related to the pathogenesis of osteoarthritis (OA), the recent research interest adds progress not only to the knowledge of the molecular signals that mediate apoptosis but also to find new therapeutic targets. This study attempts to investigate the differential expression of BCL2 family genes in the articular cartilage of an experimental animal model of OA. METHODS: In total, 26 New Zealand white rabbits underwent an anterior cruciate ligament transaction, 26 more were subjected to a placebo surgery and 18 specimens constituted the control non-operated group. Thirteen weeks later, samples of cartilage from the osteoarthritic and non-osteoarthritic knees were collected and subjected to analysis of the BCL2, BAX and BCL2L12 gene expression at the mRNA level. RESULTS: Installed osteoarthritic alterations of varied intensity and of grade 1 up to grade 5, were confirmed according to the OARSI system. Contrary to the physiologically healthy samples, in the osteoarthritic samples the mRNA expression levels of BAX and BCL2L12 genes were found significantly upregulated by signals which can activate apoptosis. However, the difference between BCL2 mRNA expression levels in healthy and osteoarthritic samples was not supported statistically. CONCLUSIONS: Since apoptosis is the main feature of the cartilage degeneration in OA, the effective inhibition of apoptosis of chondrocytes can provide novel and interesting therapeutic strategies for the treatment of OA. Therefore, BAX and BCL2L12 are highlighted as potential therapeutic targets in OA.
Authors: Alexander H Stegh; Hyunggee Kim; Robert M Bachoo; Kristin L Forloney; Jean Zhang; Harald Schulze; Kevin Park; Gregory J Hannon; Junying Yuan; David N Louis; Ronald A DePinho; Lynda Chin Journal: Genes Dev Date: 2007-01-01 Impact factor: 11.361
Authors: Spyridon Christodoulou; Dimitra K Alexopoulou; Christos K Kontos; Andreas Scorilas; Iordanis N Papadopoulos Journal: Tumour Biol Date: 2014-01-16
Authors: Shi Sirong; Chen Yang; Tian Taoran; Li Songhang; Lin Shiyu; Zhang Yuxin; Shao Xiaoru; Zhang Tao; Lin Yunfeng; Cai Xiaoxiao Journal: Bone Res Date: 2020-02-10 Impact factor: 13.567
Authors: Shi Sirong; Chen Yang; Tian Taoran; Li Songhang; Lin Shiyu; Zhang Yuxin; Shao Xiaoru; Zhang Tao; Lin Yunfeng; Cai Xiaoxiao Journal: Bone Res Date: 2020-02-10 Impact factor: 13.567